In cervical cancer, ADAR1 modified the BLCAP transcripts at two sites (tyrosine-to-cysteine and glutamine-to-arginine) in its coding region-tyrosine-X-X-glutamine (YXXQ) motif that binds to Src-homology 2 domain of signal transducer and activator of transcription 3 (STAT3) and inhibits its phosphorylation. Here, STAT3 is linked to cervical cancer.